MARKET WRAP: JSE gains as EU stimulus leads to risk-on moves

The JSE had its third day of gains on Tuesday as progress in creating a Covid-19 vaccine and the EU’s stimulus deal boosted appetite for riskier assets.

Markets rallied following reports that an experimental vaccine trial by Oxford University and British-Swedish pharmaceutical group AstraZeneca induced an immune response. Data showed that a vaccine trial by German BioNTech and US pharmaceutical firm Pfizer also showed positive results and that it is safe for humans.

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

MARKET WRAP: JSE firms on ongoing stimulus talks‘The dollar was firmer against most currencies today with the exception of the euro as markets await the outcome of EU stimulus talks’
La source: BDliveSA - 🏆 12. / 63 Lire la suite »

Euro hovers near 4-month peak as market looks to EU summitThe euro hovered near four-month highs against the dollar as investors held on to hopes that European leaders would hammer out an economic rescue deal.
La source: eNCA - 🏆 49. / 51 Lire la suite »

Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
La source: BDliveSA - 🏆 12. / 63 Lire la suite »

WATCH: How lockdown has laid waste to the labour marketPrincipal investigator of the NIDS CRAM project Nic Spaull talks to Business Day TV about what their survey revealed.
La source: BDliveSA - 🏆 12. / 63 Lire la suite »

Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
La source: BDliveSA - 🏆 12. / 63 Lire la suite »